Accuracy of ultrasound in localization of breast boost field.

Radiother Oncol

Department of Radiation Oncology, Princess Margaret Hospital and University of Toronto, 610 University Avenue, Toronto, ON, Canada M5G 2M9.

Published: July 2004

Background And Purpose: To prospectively compare diagnostic ultrasound to the 'gold standard' of surgical clips for localization of the lumpectomy site for electron boost irradiation.

Patients And Methods: Consecutive breast cancer patients referred following lumpectomy underwent diagnostic ultrasound in radiation treatment position 21-100 days post-surgery. All patients had 3-6 surgical clips defining the excision cavity. The site was marked on the skin and depth was measured. Target depth was the deepest aspect of the cavity plus a 1 cm deep margin. Treatment fields were prescribed with a 2 cm margin on the cavity, and electron energy was chosen to cover the target depth. Surgical clip position was assessed on orthogonal simulator films.

Results: Localizations were performed in 54 breasts (52 women). The mean interval post-surgery was 53 (SD 17) days. Overall, 35/54 (65%) of localizations were adequate, 15/54 (28%) were marginal and 4/54 (7%) were inadequate. Regression showed that lower patient weight (r=-0.37, P=0.006) predicted adequacy of localization, with better accuracy in lighter women.

Conclusions: The accuracy rate for ultrasound exceeds the 20-50% reported for clinical localization. Diagnostic ultrasound may be used to improve the accuracy when surgical clips are not present.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2004.03.013DOI Listing

Publication Analysis

Top Keywords

diagnostic ultrasound
12
surgical clips
12
target depth
8
accuracy
4
accuracy ultrasound
4
localization
4
ultrasound localization
4
localization breast
4
breast boost
4
boost field
4

Similar Publications

Objective: Using F-FDG PET/CT metabolic parameters to differentiate post-transplant lymphoproliferative disorder (PTLD) and reactive lymphoid hyperplasia (RLH), and PTLD subtypes.

Methods: F-FDG PET/CT and clinical data from 63 PTLD cases and 19 RLH cases were retrospectively collected. According to the 2017 WHO classification, PTLD was categorized into four subtypes: nondestructive (ND-PTLD), polymorphic (P-PTLD), monomorphic (M-PTLD), and classic Hodgkin.

View Article and Find Full Text PDF

Rheumatoid arthritis (RA) is a chronic autoimmune disease marked by systemic inflammation. While RA primarily affects the joints, its systemic effects may lead to an increased cerebro- and cardiovascular risk. Atherosclerosis of the carotid arteries is a significant risk factor for cerebrovascular events and serves as a surrogate marker for cardiovascular risk.

View Article and Find Full Text PDF

Impact of topical and systemic therapy on carotid-intima media thickness in psoriasis.

Arch Dermatol Res

January 2025

Cerrahpasa Faculty of Medicine, Department of Dermatology, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Atherosclerosis, in which chronic inflammation is also effective in it's pathogenesis, is an important cause of morbidity and mortality in psoriasis patients. Early diagnosis and management of atherosclerosis is important. Measurement of carotid intima media thickness is a method used to determine subclinical atherosclerosis.

View Article and Find Full Text PDF

Multicenter study of thermal ablation versus partial thyroidectomy for paratracheal papillary thyroid microcarcinoma.

Eur Radiol

January 2025

Department of Ultrasound, The First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China.

Objective: To compare the clinical outcomes of patients with unifocal paratracheal papillary thyroid microcarcinoma (PTMC) after thermal ablation (TA) vs. partial thyroidectomy (PT).

Materials And Methods: This retrospective multicenter study included 436 patients with unifocal, clinical N0 paratracheal PTMC who underwent TA (210 patients) or PT (236 patients) between June 2014 and December 2020.

View Article and Find Full Text PDF

Background: Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy of ventral intermediate (Vim) nucleus is useful to treat drug-resistant tremor-dominant Parkinson's disease (TdPD), but tremor relapse may occur. Predictors of relapse have been poorly investigated so far.

Objective: The aim of this study is to evaluate the role of clinico-demographic, procedural, and neuroradiological variables in determining clinical response, relapse, and adverse events (AEs) in TdPD after MRgFUS Vim-thalamotomy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!